Significant genetic correlations were found between pediatric neuropsychiatric conditions and various ocular disorders.
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Spread the loveThe recent announcement from a multinational research team regarding a novel CRISPR gene therapy has sparked excitement and hope among millions affected by genetic blindness. In a ...
Xiuqian Mu, MD, PhD, professor of ophthalmology at the Jacobs School of Medicine and Biomedical Sciences, has received additional funding from the National Eye Institute for his research on retinal ...
The ARVO poster presentation and a video recording of Dr. Pennesi’s summary of Cohort 1 Baseline Demographics and Key ...
In recent years, advances in molecular genetics have impacted the understanding and the classification of hereditary retinal and optic nerve disease perhaps more than any other group of eye diseases.
A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results